𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Association of p53 gene mutation with decreased chemosensitivity in human malignant gliomas

✍ Scribed by Yasuo Iwadati; Shuichi Fujimoto; Masatoshi Tagawa; Hiroki Namba; Kanji Sueyoshi; Masayoshi Hirose; Shigeru Sakiyama


Publisher
John Wiley and Sons
Year
1996
Tongue
French
Weight
507 KB
Volume
69
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Loss of p53 function is involved in tumorigenesis of various human cancers, but the relation between mutation of the p53 tumor-suppressor gene and the chemo-and radiosensitivity of tumors remains unclear. Mutated p53 gene in malignant glioma is often associated with progression and recurrence of rnalignancy, and these events are closely linked with increased resistance to both chemotherapy and radiation. We have examined the status of the p53 gene in malignant gliomas obtained from 34 patients (glioblastoma: 29 cases, anaplastic astrocytomas: 5 cases). The chemosensitivities of these specimens using 28 kinds of anti-cancer agents were determined using an in vitro assay system. Overall, I 2 mutated cases of p53 gene were found in malignant glioma samples. The mean numbers of effective agents were 0.58 for the tumor samples with p53 mutations and 5.00 for tumors without mutations. Our data indicate that p53 gene mutation predisposes to decreased cell killing via chemotherapy in malignant nliornas.

.,


πŸ“œ SIMILAR VOLUMES


Incidence of germ-line p53 mutations in
✍ You-Jun Li; Marc Sanson; KhΓͺ Hoang-Xaun; Jean-Yves Delattre; Michel Poisson; Gil πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 608 KB

## Abstract Epidemiological studies on intracranial tumors have suggested that the observed familial aggregation of a proportion of gliomas may be due to inherited predisposition to their development. In the Li‐Fraumeni syndrome (LFS) associated with germ‐line mutations of the __p53__ gene, nervous

Involvement of p53 gene mutations in hum
✍ Tsuyoshi Honda; Hidenori Kato; Toshiro Imamura; Tomonao Gima; Jun-Ichi Nishida; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 1019 KB

Mutations in the p53 gene are associated with a wide variety of human malignancies. Point mutation in one allele and loss of the remaining one generally lead to inactivation of p53 protein. A high frequency of allelic losses corresponding to the I7p 13.3 region that contained the p53 gene sequence

p53 mutations in human tumors with chime
✍ Richard Hamelin; Jessica Zucman; Thomas Melot; Olivier Delatre; Gilles Thomas πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 French βš– 549 KB

Mutations iin these DNA samples have already been reported under different coded numbers (Hamelin et al., 1993).-?The deleted sequence is GGTTGCCCAGGGT starting at the 34th bp of intron 5. It does not include known important consensus sequences for splicing.-"xon number. -"he number of alleles is d

A mutational hot spot in the p53 gene is
✍ Hideaki Oda; Yoko Nakatsuru; Yasuo Imai; Haruhiko Sugimura; Takatoshi Ishikawa πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 918 KB

## Abstract Hepatoblastomas generally appear in children aged 2 or 3 years old and arise from apparently normal, noncirrhotic liver. To elucidate any possible role of p53 mutations in their genesis, we amplified and sequenced exons 5 to 8 of the p53 gene in 10 cases of hepatoblastoma. Somatic mutat

Reappraisal of p53 mutations in human ma
✍ Mitsuhiro Tada; Richard D. Iggo; Francois Waridel; Michimasa Nozaki; Ryoji Matsu πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 282 KB πŸ‘ 1 views

We previously reported clonal expansion of p53 mutations in malignant astrocytic tumors detected with a yeast p53 functional assay that measures mutant p53 alleles quantitatively and loss of p53 transcriptional competence qualitatively (Tada et al., Int J Cancer 67:447-450, 1996). This method select